Navigation Links
Microparts interest group workshop
Date:8/7/2009

Recent advances in modern manufacturing techniques has made it possible to manufacture small and complex components to extremely high accuracies. In direct response to the extreme demands of quality assurance for the measurement of size, form and position of microsystem parts, extensive research is being carried out in the area of geometrical measurement on the micro-scale.

'Microparts' is a joint EURAMET research project in the area of micro co-ordinate metrology for miniature components. VSL, NPL, PTB and METAS are collaborating on the project in all aspects of micro CMM technology including the development of novel contact, optical and XCT probing techniques, machine calibration, stability, traceability and calibration artefacts. The workshop aims to disseminate the work of the project to the wider audience and discuss related research and development topics.

Topics include:

  • Updates on the development of novel micro-CMM probes
  • Development of micro-CMM platforms
  • Calibration and traceability of micro-CMM platforms
  • Integrated micro metrology and micro manufacturing techniques

A workshop dinner will be held on the evening of the 28th October


'/>"/>

Contact: Joe Meaney
joe@proofcommunication.com
44-845-680-1864
National Physical Laboratory
Source:Eurekalert

Page: 1

Related biology technology :

1. Baseline Research Indicates High Interest in Centocor-Ortho Biotechs SIMPONI(R)
2. Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again
3. Xspray Expands to Meet Pharmas Interest in its Ground-Breaking Particle Production Technology
4. Managing Conflict of Interest Disclosures Simplified for Healthcare Organizations
5. China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
6. deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
7. CTI Receives the Second Payment of $6.5 million Associated with the Sale of Interest in Zevalin Joint Venture
8. China Biologic Products Completes Acquisition of 35% Interest in Xian Huitian Blood Products Co., Ltd.
9. Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million
10. Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
11. Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 Proove Biosciences ... Medicine, is excited to announce the launch of ... Optimize the Management of Pain”. , The continuing ... for the next year. The focus of the ... recognize inadequate pain treatments, integrate appropriate pain management ...
(Date:3/4/2015)... SEOUL, South Korea , March 4, 2015 /PRNewswire/ ... based biopesticide company, in August of last year. As ... with Kyung Bon Koo continuing his role ... Selakovic , President of Vegalab S.A., will work alongside ... Photo - http://photos.prnewswire.com/prnh/20150303/179218 ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
(Date:3/3/2015)... , March 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... Global Healthcare Conference in Miami, FL ... David A. Ramsay , Chief Financial Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
Breaking Biology Technology:Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
... everywhere from the air we breathe and the food we ... innocuous or even beneficial, and only a handful pose any threat ... intruder? , Research from the University of Wisconsin-Madison suggests the ... A study appearing online this week in the Proceedings of ...
... the United ... States and Canada, INDIANAPOLIS, ... partnership that will allow Roche to market,the first line of cardiovascular ... 200 (Rapid Analyte Measurement Platform), is,based on RAMP technology that is ...
... Calif., July 28 /Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Products ... Kiwa Bio-Tech Products (Shandong) Co., Ltd. (Kiwa ... million (over US$21,million) with Jilin Tianma Science ... distributors. Delivery of products under these contracts ...
Cached Biology Technology:Symbiotic microbes induce profound genetic changes in their hosts 2Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests 2Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests 3Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract 2Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract 3
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
(Date:2/13/2015)... ACT Genomics Co., Ltd., a cancer ... cancer genomic information into precision diagnosis and personalized ... US$ 8 million in the its first private funding ... Taiwan , ACT Genomics has developed comprehensive ... to implement next generation sequencing (NGS) and multiplex ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... invasive species of plant called common reed, grows rapidly into ... to Great Lakes coastal wetlands. Early treatment is the key ... invasive reeds be eradicated before they take over their environment ... do know, thanks to scientists from Michigan Technological University,s Michigan ...
... snackers? A new Cornell study finds that serving children combined ... fewer calories and be just as satisfied as those who ... eat, and they take longer to eat than potato chips. ... so much less," said Brian Wansink, professor of marketing at the ...
... Center and the Moffitt Cancer Center, led by Dr. ... imaging (MRI) method can non-invasively evaluate the cellular proliferation ... imaging method evaluates the diffusion of water in tumor ... tumor models. The results, which appear in the November ...
Cached Biology News:Following Phragmites home 2Combo-snacks of cheese and vegetables cut kids calories 2
... cells were cultured in Ham's F12K medium with ... phase of growth. In order to keep the ... in acetone-methanol. The cells are arrayed on a ... wells surface specifically treated to enhance cellular attachment ...
CELLine System cultivation flask (for secreted products)...
... K28/86.2, PDZ Domain GenBank Accession ... GST fusion to residues 77-299 of ... pH 7.4, 0.075M NaCl containing 0.05% ... by immunoblot on rat brain microsomal ...
... western blots ,• Optically clear plastic construction ... western blots. The reduced size (60 x ... tray requires less dye and antibodies resulting ... user. Pour spouts in each corner facilitate ...
Biology Products: